50.48 USD
-2.26
4.29%
At close Updated Sep 17, 4:00 PM EDT
Pre-market
After hours
50.48
0.00
0%
1 day
-4.29%
5 days
-4.23%
1 month
-5.45%
3 months
-3.37%
6 months
-17.77%
Year to date
-25.05%
1 year
-32.51%
5 years
-39.11%
10 years
-2.68%
 

About: Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgeries. The Company's products are used by surgeons and other healthcare professionals in a variety of specialties including orthopedics, general surgery, gynecology, thoracic surgery and gastroenterology. Geographically operates in USA, Europe, Middle East & Africa, Asia Pacific and North America. Majority is revenue is from USA.

Employees: 3,900

0
Funds holding %
of 7,463 funds
Analysts bullish %

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

134% more call options, than puts

Call options by funds: $3.91M | Put options by funds: $1.67M

0% more repeat investments, than reductions

Existing positions increased: 95 | Existing positions reduced: 95

4% less first-time investments, than exits

New positions opened: 43 | Existing positions closed: 45

2% less funds holding

Funds holding: 278 [Q1] → 272 (-6) [Q2]

2.22% less ownership

Funds ownership: 115.16% [Q1] → 112.93% (-2.22%) [Q2]

15% less capital invested

Capital invested by funds: $2.15B [Q1] → $1.82B (-$328M) [Q2]

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

Low target
$68
35% upside
Avg. target
$68
35% upside
High target
$68
35% upside

1 analyst rating

positive
100%
neutral
0%
negative
0%
Piper Sandler
Matt OBrien
$68
Overweight
Maintained
31 Jul 2025

Financial journalist opinion

Based on 6 articles about CNMD published over the past 30 days

Positive
Zacks Investment Research
21 hours ago
Here's Why Conmed (CNMD) is a Strong Value Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Here's Why Conmed (CNMD) is a Strong Value Stock
Neutral
Business Wire
8 days ago
CONMED Corporation Adds Kim Kelderman to its Board of Directors
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that Kim Kelderman will be joining its Board of Directors effective September 8, 2025. “My fellow directors and I are delighted to welcome Kim to the board,” said LaVerne Council, Chair of CONMED's Board of Directors. “Kim brings extensive global leadership experience across life sciences businesses, with a strong track record in innovation and strategy. Kim's skills and insights will be valuable additions to the boar.
CONMED Corporation Adds Kim Kelderman to its Board of Directors
Positive
Zacks Investment Research
20 days ago
Here's Why Conmed (CNMD) is a Strong Momentum Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here's Why Conmed (CNMD) is a Strong Momentum Stock
Neutral
Zacks Investment Research
21 days ago
Here's Why You Should Retain CONMED Stock in Your Portfolio for Now
CNMD's growth drivers - AirSeal, Buffalo Filter, BioBrace, and Foot & Ankle - are offsetting tariffs and supply risks, making the stock worth retaining.
Here's Why You Should Retain CONMED Stock in Your Portfolio for Now
Positive
Zacks Investment Research
23 days ago
Why Conmed (CNMD) is a Top Value Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Why Conmed (CNMD) is a Top Value Stock for the Long-Term
Positive
Zacks Investment Research
26 days ago
Here's Why Conmed (CNMD) is a Strong Growth Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Here's Why Conmed (CNMD) is a Strong Growth Stock
Positive
Zacks Investment Research
1 month ago
Why Conmed (CNMD) is a Top Momentum Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Why Conmed (CNMD) is a Top Momentum Stock for the Long-Term
Neutral
Business Wire
1 month ago
CONMED Corporation Announces Quarterly Cash Dividend
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that its Board of Directors declared a quarterly cash dividend of $0.20 per share on August 7, 2025, payable on October 3, 2025, to all shareholders of record as of September 15, 2025. About CONMED Corporation CONMED is a medical technology company that provides devices and equipment for surgical procedures. The Company's products are used by surgeons and other healthcare professionals in a variety of specialties, inc.
CONMED Corporation Announces Quarterly Cash Dividend
Positive
Zacks Investment Research
1 month ago
Why Conmed (CNMD) is a Top Growth Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Why Conmed (CNMD) is a Top Growth Stock for the Long-Term
Positive
The Motley Fool
1 month ago
Conmed (CNMD) Q2 EPS Jumps 17%
Conmed (CNMD) Q2 EPS Jumps 17%
Conmed (CNMD) Q2 EPS Jumps 17%
Charts implemented using Lightweight Charts™